Question 1

Who are some of the prominent players in the GLP-1 receptor agonist industry?

Accepted Answer

Key players in the market include Boehringer Ingelheim International GmbH, Eli Lilly and Company, Sanofi, Novo-Nordisk A/S, AstraZeneca, Pfizer, Inc., Amgen, Inc., Innovent Biologics, Inc., and PegBio Co., Ltd.

Question 2

How much is the North America GLP-1 receptor agonist industry worth?

Accepted Answer

North America held the largest share of the GLP-1 receptor agonist market in 2022 and is projected to grow at a robust CAGR through 2032, driven by a high prevalence of diabetes, increasing obesity rates, and a well-established healthcare infrastructure.

Question 3

Why is the semaglutide segment dominant in the GLP-1 receptor agonist industry?

Accepted Answer

he semaglutide segment held a dominant market share in 2023 and is projected to sustain growth through 2032 due to its efficacy in controlling blood sugar levels and promoting weight loss.

Question 4

How big is the GLP-1 receptor agonist market?

Accepted Answer

The global GLP-1 receptor agonist industry was valued at USD 24.4 billion in 2023 and is expected to grow at a 9.7% CAGR from 2024 to 2032, driven by rising incidences of type 2 diabetes and obesity globally.

GLP-1 Receptor Agonist Market Share

GLP-1 Receptor Agonist Market Share

GLP-1 Receptor Agonist Market Companies

Premium Report Details

Industries

Information

Link

Global Headquarters